Saturday, 17 November 2018

Jubilant Life Sciences raises Rs 350 Cr via NCDs

07 September 2018 | News

In a regulatory filing, the company said it has issued 3,500 NCDs of Rs 10,00,000 each for cash at par.

Image Source: Pexels

Image Source: Pexels

Jubilant Life Sciences has raised Rs 350 crore through non-convertible debentures (NCDs) on private placement basis for repayment of its existing debt and reduce the overall cost of borrowing.

In a regulatory filing, the company said it has issued 3,500 NCDs of Rs 10,00,000 each for cash at par.

The NCDs will have maturity period of 2 to 4 years and have been offered at an interest rate between 8.95 and 9.26 per cent per annum.

The NCDs will be redeemed on maturity, it added.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Click Here!




Survey Box

Will the health insurance sector receive benefits from Ayushman Bharat?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls